JLABS | Demystifying due diligence in biotech and medtech collaborations

4 July 2024 from 14:15 – 17:45

Don’t miss this chance to unlock the potential of collaborations with healthcare companies. Join this Johnson & Johnson Innovation – JLABS program and explore the intricacies of due diligence. Get step-by-step guidance, insights from insiders and industry experts, and real-life experiences.

Do you want to propel your start-up or innovative project to new heights? A collaboration or partnership with a large medtech or pharma company might be a valuable opportunity to explore. Depending on your needs, it could provide access to funding, resources, expertise, and networks which are otherwise might otherwise remain out of reach. In turn this could help to speed up development and enhance the overall probability of regulatory approval and market success for a new healthcare intervention, thus de-risking the overall development.

To a start-up company , the process of building a collaboration with a large healthcare company might seem daunting and the criteria used for assessing potential deals unclear. During this Johnson & Johnson Innovation – JLABS program we will demystify what due diligence entails, what the pitfalls are and how you might set yourself up for success.

Start-ups, early innovators and entrepreneurs are welcome to register. We also welcome stakeholders supporting these start-ups..

Back to top